9 completed, 6 terminated, 1 recruiting, 1 unknown. 8 Phase 1, 7 Phase 2, 3 Phase 3, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Terminated 5, Completed 2, Unknown 1 |
| Phase 2 | 7 | Completed 5, Recruiting 1, Terminated 1 |
| Phase 3 | 3 | Completed 1, Recruiting 1, Terminated 1 |
| Not applicable | 1 | Completed 1 |
Follow satraplatin: new trials by email Literature Review of satraplatin trials Research Report on satraplatin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer Patients Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin - Prostate Cancer Patients | Phase 2 / Phase 3 | Recruiting | Shanghai Jiao Tong University School of Medicine | 300 | 2015-01-01 | 2026-01-12 |
| Satraplatin in Children and Young Adults With Refractory Solid Tumors Including Brain Tumors Satraplatin - Solid Tumors, Brain Tumors | Phase 1 | Completed | National Cancer Institute (NCI) | 9 | 2010-12-03 | 2018-07-05 |
| Utilizing A Genomic Sig for "BRCAness" to Eval the Efficacy of Satraplatin in Men With Met. Castration Resistant Prostate Ca Satraplatin - Prostate Cancer | Phase 2 | Completed | William K. Oh | 13 | 2010-12-01 | 2018-02-13 |
| Satraplatin and Prednisone to Treat Prostate Cancer Satraplatin, prednisone - Prostate Cancer, Genetic Polymorphism | Phase 2 | Completed | National Cancer Institute (NCI) | 24 | 2008-02-19 | 2018-10-02 |
| Satraplatin and Vinorelbine in Advanced Solid Tumors Satraplatin in combo with vinorelbine - Advanced Solid Tumors | Phase 1 | Unknown | Southern Europe New Drug Organization | 27 | 2008-02-01 | 2010-10-13 |
| Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docetaxel bevacizumab, satraplatin - Prostate Cancer | Not applicable | Completed | Barbara Ann Karmanos Cancer Institute | 31 | 2007-10-01 | 2018-06-12 |
| Phase I Study of the Combination of Satraplatin and Abraxane in Advanced Cancers Satraplatin, Abraxane - Advanced Cancers | Phase 1 | Completed | Yale University | 15 | 2007-05-01 | 2013-01-23 |
| A Phase I Trial of Satraplatin Plus Radiation Therapy for Prostate Cancer Patients With Biochemical Recurrence Satraplatin plus radiation therapy - Prostate Cancer | Phase 1 | Terminated | Agennix | 2007-05-01 | 2012-03-23 | |
| Study of Satraplatin (JM-216) in Combination With Docetaxel satraplatin and docetaxel - Tumors | Phase 1 | Terminated | Agennix | 28 | 2007-03-01 | 2012-03-26 |
| Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC) Oral Satraplatin - Prostate Cancer | Phase 3 | Terminated | Agennix | 344 | 2007-02-01 | 2012-08-17 |
| A Study Comparing Sequential Satraplatin & Erlotinib to Erlotinib in Unresectable Stage 3/4 Non-small-cell Lung Cancer (NSCLC) Erlotinib, Satraplatin - Lung Cancer | Phase 2 | Completed | Agennix | 100 | 2006-07-01 | 2012-08-07 |
| Study of Satraplatin With Capecitabine to Treat Advanced Solid Malignancies satraplatin and capecitabine - Malignancies | Phase 1 | Terminated | Agennix | 24 | 2006-05-01 | 2012-03-23 |
| A Phase I Study of the Oral Platinum Agent Satraplatin in Combination With Weekly Docetaxel Satraplatin - Tumors, Prostate Cancer | Phase 1 | Terminated | Agennix | 25 | 2006-03-01 | 2012-05-10 |
| Satraplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer Satraplatin in combination with Paclitaxel - Non-small Cell Lung Cancer | Phase 2 | Completed | Agennix | 40 | 2005-12-01 | 2012-04-30 |
| Satraplatin for Patients With Metastatic Breast Cancer (MBC) Satraplatin - Metastatic Breast Cancer | Phase 2 | Completed | Agennix | 40 | 2005-11-01 | 2012-03-28 |
| Satraplatin for Locally Advanced Non-Small Cell Lung Cancer With Simultaneous Radiotherapy Satraplatin - Carcinoma, Non-small Cell Lung, Lung Cancer | Phase 1 / Phase 2 | Terminated | Agennix | 20 | 2004-08-01 | 2012-08-17 |
| Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen Satraplatin, Prednisone - Prostate Cancer, Hormone Refractory Prostate Cancer | Phase 3 | Completed | Agennix | 2003-09-01 | 2012-08-07 |
Prostatic Neoplasms (8) · Neoplasms (4) · Carcinoma, Non-Small-Cell Lung (3) · Lung Neoplasms (2) · Adenocarcinoma of Lung (1) · Adenocarcinoma, Bronchiolo-Alveolar (1) · Brain Neoplasms (1) · Breast Neoplasms (1) · Neoplasm Metastasis (1)
Agennix (10) · National Cancer Institute (NCI) (2) · Barbara Ann Karmanos Cancer Institute (1) · Shanghai Jiao Tong University School of Medicine (1) · Southern Europe New Drug Organization (1) · William K. Oh (1) · Yale University (1)
United States (15) · Argentina (1) · Belgium (1) · Canada (1) · Chile (1) · China (1) · Croatia (1) · France (1) · Germany (1) · Hungary (1) · Israel (1) · Italy (1) · Netherlands (1) · Peru (1) · Poland (1)
Brigitte C Widemann, M.D. (1) · Corey Langer, MD (1) · Cristiana Sessa, MD (1) · George Wilding, MD (1) · Hari Deshpande, M.D. (1) · Howard Sandler, MD (1) · Joyce O'Shaughnessy, MD (1) · Michael Petrone, MD (1) · Philippe Pultar, MD (1) · Ulka N. Vaishampayan, MD (1) · William Gradishar, MD (1) · William K Oh, M.D. (1) · William L Dahut, M.D. (1) · Yu Sun, Ph.D (1)
P30CA022453 (1)